| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
44,021 |
39,087 |
$5.32M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
7,893 |
7,160 |
$4.70M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,809 |
12,545 |
$4.12M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,800 |
19,742 |
$2.77M |
| G0378 |
Hospital observation service, per hour |
12,820 |
8,700 |
$2.03M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,934 |
8,116 |
$2.01M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
308,781 |
244,456 |
$1.88M |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,416 |
6,700 |
$1.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,987 |
14,627 |
$1.59M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,063 |
3,872 |
$1.48M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,977 |
4,673 |
$1.42M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21,913 |
7,854 |
$1.39M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,482 |
3,284 |
$1.20M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
7,228 |
4,278 |
$1.13M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,829 |
7,720 |
$1.11M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
6,631 |
6,106 |
$1.09M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,518 |
3,395 |
$1.04M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
3,065 |
1,984 |
$918K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25,817 |
23,487 |
$848K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
11,546 |
10,611 |
$796K |
| 36512 |
|
253 |
239 |
$783K |
| 80053 |
Comprehensive metabolic panel |
138,723 |
107,395 |
$770K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,907 |
7,452 |
$703K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,090 |
7,360 |
$694K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,158 |
1,092 |
$640K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25,913 |
23,516 |
$638K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,691 |
4,667 |
$630K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
21,105 |
19,924 |
$524K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
137,746 |
105,926 |
$497K |
| 71046 |
Radiologic examination, chest; 2 views |
18,211 |
16,215 |
$494K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
3,328 |
3,200 |
$494K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
370 |
153 |
$461K |
| J3490 |
Unclassified drugs |
97,496 |
41,331 |
$455K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,656 |
2,526 |
$437K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
427 |
352 |
$425K |
| 87631 |
|
4,303 |
3,690 |
$418K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,899 |
4,308 |
$412K |
| 59025 |
Fetal non-stress test |
2,830 |
1,466 |
$399K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
32,599 |
25,053 |
$387K |
| Q3014 |
Telehealth originating site facility fee |
27,595 |
23,401 |
$371K |
| J2323 |
Injection, natalizumab, 1 mg |
242 |
200 |
$368K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,441 |
4,003 |
$347K |
| 74183 |
|
993 |
937 |
$347K |
| 84443 |
Thyroid stimulating hormone (TSH) |
33,165 |
31,410 |
$341K |
| 99152 |
|
7,096 |
6,533 |
$338K |
| 76818 |
|
3,524 |
1,421 |
$333K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
18,270 |
16,491 |
$326K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
326 |
313 |
$310K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,147 |
2,725 |
$310K |
| 96415 |
|
1,741 |
1,181 |
$309K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,071 |
841 |
$308K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14,459 |
10,949 |
$303K |
| 36415 |
Collection of venous blood by venipuncture |
117,113 |
97,630 |
$287K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13,465 |
9,805 |
$284K |
| 95806 |
|
865 |
846 |
$284K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,273 |
7,521 |
$272K |
| 20610 |
|
1,686 |
1,479 |
$258K |
| 83655 |
|
16,878 |
16,683 |
$251K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,803 |
9,340 |
$242K |
| 93308 |
|
746 |
673 |
$240K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,308 |
3,135 |
$232K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29,700 |
28,021 |
$229K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
598 |
564 |
$223K |
| 93975 |
|
2,914 |
2,721 |
$213K |
| 90670 |
|
3,171 |
3,072 |
$213K |
| 82805 |
|
3,941 |
3,204 |
$212K |
| 97165 |
|
3,253 |
2,935 |
$209K |
| 90686 |
|
14,222 |
13,602 |
$208K |
| 93976 |
|
2,173 |
2,047 |
$202K |
| 71250 |
|
2,034 |
1,925 |
$200K |
| 93971 |
|
1,748 |
1,635 |
$198K |
| 90651 |
|
2,036 |
1,965 |
$191K |
| 70486 |
|
2,078 |
1,927 |
$186K |
| 31575 |
|
727 |
679 |
$185K |
| 64615 |
|
553 |
519 |
$182K |
| 76801 |
|
2,776 |
2,366 |
$180K |
| 90837 |
Psychotherapy, 53 minutes with patient |
4,473 |
2,324 |
$173K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
34,874 |
25,380 |
$171K |
| 88142 |
|
8,119 |
7,609 |
$170K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
464 |
439 |
$169K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
5,091 |
4,674 |
$166K |
| 80197 |
|
17,684 |
9,634 |
$165K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,848 |
2,584 |
$163K |
| 80061 |
Lipid panel |
22,729 |
21,522 |
$161K |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
975 |
903 |
$160K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,986 |
3,250 |
$160K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
10,863 |
9,396 |
$160K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,209 |
9,201 |
$159K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,906 |
1,054 |
$158K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
852 |
763 |
$153K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,269 |
16,871 |
$153K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,050 |
1,943 |
$149K |
| 36591 |
|
4,823 |
3,144 |
$149K |
| 64643 |
|
300 |
257 |
$143K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,722 |
1,571 |
$138K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
769 |
721 |
$137K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,369 |
1,869 |
$136K |
| 93970 |
|
930 |
870 |
$136K |
| 49083 |
|
323 |
146 |
$136K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
21,149 |
19,293 |
$134K |
| 76536 |
|
1,096 |
1,025 |
$133K |
| 90715 |
|
6,620 |
6,325 |
$132K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
25,634 |
17,490 |
$127K |
| 85027 |
|
29,272 |
22,887 |
$126K |
| 92557 |
|
1,784 |
1,726 |
$125K |
| 83880 |
|
8,641 |
7,294 |
$124K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
9,932 |
9,204 |
$123K |
| 92134 |
|
3,507 |
3,106 |
$121K |
| 77336 |
|
1,086 |
513 |
$121K |
| 73630 |
|
3,877 |
3,276 |
$121K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
986 |
549 |
$119K |
| 73610 |
|
3,583 |
3,070 |
$118K |
| 72100 |
|
3,070 |
2,860 |
$118K |
| 90791 |
Psychiatric diagnostic evaluation |
2,105 |
1,937 |
$118K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,742 |
649 |
$117K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
179 |
175 |
$116K |
| 76641 |
|
960 |
772 |
$115K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,814 |
3,646 |
$115K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
103,875 |
25,075 |
$115K |
| 81025 |
|
22,562 |
20,131 |
$113K |
| 87480 |
|
11,337 |
10,055 |
$113K |
| 70496 |
|
471 |
426 |
$112K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
180 |
166 |
$110K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,181 |
1,065 |
$109K |
| 70491 |
|
439 |
414 |
$109K |
| 70355 |
|
2,527 |
2,377 |
$108K |
| 84439 |
|
12,348 |
11,677 |
$108K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
150 |
147 |
$107K |
| J1453 |
Injection, fosaprepitant, 1 mg |
600 |
338 |
$106K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,119 |
12,905 |
$105K |
| 97597 |
|
772 |
604 |
$105K |
| 83735 |
|
40,213 |
24,322 |
$103K |
| 87660 |
|
11,495 |
10,206 |
$103K |
| 92083 |
|
3,030 |
2,739 |
$102K |
| 87536 |
|
2,585 |
2,395 |
$100K |
| 73030 |
|
3,448 |
2,937 |
$98K |
| 97161 |
|
3,209 |
2,979 |
$96K |
| 73562 |
|
2,863 |
2,392 |
$93K |
| 93798 |
|
1,659 |
248 |
$93K |
| 86850 |
|
8,318 |
7,259 |
$92K |
| 87510 |
|
11,334 |
10,053 |
$91K |
| 82728 |
|
9,990 |
9,329 |
$91K |
| 73130 |
|
2,747 |
2,272 |
$90K |
| 82607 |
|
8,371 |
7,955 |
$90K |
| 87497 |
|
2,868 |
1,596 |
$86K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,341 |
13,622 |
$85K |
| 83970 |
|
3,003 |
2,798 |
$84K |
| 93321 |
|
1,301 |
1,176 |
$84K |
| 96417 |
|
1,428 |
836 |
$84K |
| J2704 |
Injection, propofol, 10 mg |
10,931 |
8,609 |
$82K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
729 |
695 |
$82K |
| 86780 |
|
9,014 |
8,268 |
$80K |
| 73560 |
|
2,576 |
2,175 |
$80K |
| 76820 |
|
980 |
374 |
$79K |
| 86923 |
|
1,831 |
1,402 |
$78K |
| 90677 |
|
779 |
758 |
$77K |
| 88307 |
|
1,107 |
961 |
$76K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,802 |
991 |
$73K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,031 |
619 |
$73K |
| 73110 |
|
2,242 |
1,844 |
$71K |
| 94618 |
|
391 |
374 |
$71K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,378 |
4,115 |
$70K |
| 73502 |
|
2,227 |
1,949 |
$70K |
| 95812 |
|
201 |
195 |
$68K |
| 95886 |
|
797 |
778 |
$68K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,126 |
1,703 |
$67K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,340 |
2,237 |
$66K |
| 81003 |
|
27,745 |
23,658 |
$66K |
| 77080 |
|
1,542 |
1,486 |
$65K |
| 72040 |
|
1,813 |
1,691 |
$65K |
| 87081 |
|
8,892 |
8,336 |
$64K |
| 87507 |
|
204 |
197 |
$63K |
| 58300 |
|
472 |
419 |
$62K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
108 |
104 |
$62K |
| J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg |
30 |
12 |
$61K |
| 86900 |
|
9,548 |
8,113 |
$61K |
| 86140 |
|
10,173 |
9,208 |
$60K |
| 94375 |
|
1,615 |
1,447 |
$59K |
| 90750 |
|
894 |
853 |
$59K |
| 94729 |
|
1,732 |
1,678 |
$59K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,431 |
3,285 |
$57K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
3,249 |
2,644 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,008 |
4,791 |
$55K |
| 93325 |
|
580 |
526 |
$55K |
| 72141 |
|
366 |
343 |
$55K |
| 77386 |
|
234 |
24 |
$54K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
18,005 |
14,187 |
$53K |
| 71045 |
Radiologic examination, chest; single view |
8,553 |
7,357 |
$53K |
| 92250 |
|
1,792 |
1,551 |
$52K |
| 86803 |
|
6,072 |
5,612 |
$52K |
| 97162 |
|
2,726 |
2,566 |
$51K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,342 |
4,570 |
$51K |
| 31231 |
|
317 |
295 |
$51K |
| 0097U |
|
500 |
459 |
$50K |
| 87340 |
|
6,658 |
6,191 |
$50K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
913 |
671 |
$50K |
| 84484 |
|
20,453 |
13,640 |
$50K |
| 74018 |
|
1,804 |
1,601 |
$49K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
77 |
74 |
$49K |
| 73590 |
|
1,956 |
1,726 |
$49K |
| J0897 |
Injection, denosumab, 1 mg |
189 |
166 |
$49K |
| 85610 |
|
19,775 |
13,375 |
$48K |
| 94060 |
|
978 |
943 |
$48K |
| 88341 |
|
1,298 |
1,032 |
$48K |
| 36592 |
|
1,710 |
832 |
$48K |
| 99153 |
Mod sedat endo service >5yrs |
4,475 |
4,124 |
$47K |
| 76830 |
Ultrasound, transvaginal |
1,997 |
1,884 |
$47K |
| 74174 |
|
341 |
303 |
$47K |
| 73552 |
|
1,370 |
1,235 |
$47K |
| 90734 |
|
1,086 |
1,051 |
$46K |
| 84466 |
|
7,444 |
6,978 |
$46K |
| 88342 |
|
2,543 |
2,270 |
$45K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14,408 |
11,820 |
$45K |
| 72156 |
|
299 |
275 |
$45K |
| 84100 |
|
24,369 |
14,497 |
$45K |
| 96367 |
|
1,977 |
1,328 |
$45K |
| 12001 |
|
210 |
199 |
$44K |
| 86235 |
|
3,891 |
1,272 |
$44K |
| 76770 |
|
324 |
306 |
$44K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
545 |
240 |
$44K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
290 |
269 |
$44K |
| 70498 |
|
536 |
470 |
$43K |
| 86762 |
|
3,323 |
3,082 |
$43K |
| 94761 |
|
5,986 |
5,238 |
$43K |
| 94726 |
|
1,405 |
1,367 |
$43K |
| 84702 |
|
3,571 |
2,729 |
$42K |
| A0210 |
Non-emergency transportation: ancillary: meals-escort |
3,929 |
629 |
$42K |
| 86480 |
|
1,362 |
1,277 |
$42K |
| 82784 |
|
5,287 |
3,958 |
$42K |
| J7050 |
Infusion, normal saline solution, 250 cc |
17,323 |
8,355 |
$41K |
| 87522 |
Neg quan hep c or qual rna |
1,351 |
1,274 |
$41K |
| A9270 |
Non-covered item or service |
61,936 |
6,614 |
$41K |
| 90680 |
|
1,636 |
1,596 |
$41K |
| 93296 |
|
1,812 |
1,761 |
$41K |
| 70320 |
|
572 |
559 |
$41K |
| 87077 |
|
8,287 |
7,178 |
$41K |
| 83540 |
|
9,731 |
9,157 |
$40K |
| 0099U |
|
331 |
313 |
$40K |
| 36430 |
|
816 |
517 |
$40K |
| 92550 |
|
425 |
409 |
$40K |
| 82570 |
|
10,973 |
10,011 |
$39K |
| A0180 |
Non-emergency transportation: ancillary: lodging-recipient |
2,579 |
448 |
$39K |
| 90732 |
|
2,003 |
1,919 |
$39K |
| 82746 |
|
4,953 |
4,657 |
$38K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,417 |
775 |
$37K |
| 93017 |
|
385 |
374 |
$37K |
| 93225 |
|
658 |
628 |
$37K |
| 88185 |
|
680 |
577 |
$36K |
| 0124A |
|
1,217 |
1,176 |
$36K |
| 96411 |
|
182 |
108 |
$35K |
| 96523 |
|
682 |
494 |
$35K |
| J0475 |
Injection, baclofen, 10 mg |
111 |
93 |
$35K |
| 80074 |
|
1,954 |
1,815 |
$35K |
| 86787 |
|
3,753 |
3,482 |
$34K |
| C8957 |
Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump |
206 |
188 |
$34K |
| 92133 |
|
1,680 |
1,500 |
$34K |
| 72197 |
|
130 |
120 |
$33K |
| 76882 |
|
259 |
239 |
$33K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,495 |
1,304 |
$33K |
| A4217 |
Sterile water/saline, 500 ml |
6,467 |
4,114 |
$33K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
333 |
291 |
$32K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,027 |
916 |
$32K |
| 87799 |
|
2,086 |
1,425 |
$32K |
| 73140 |
|
895 |
757 |
$32K |
| 96401 |
|
981 |
630 |
$32K |
| 86359 |
|
1,701 |
1,572 |
$31K |
| 84403 |
|
2,131 |
2,028 |
$31K |
| 90647 |
|
1,981 |
1,913 |
$31K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
482 |
461 |
$30K |
| 87070 |
|
4,911 |
4,467 |
$30K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
87 |
86 |
$30K |
| 81001 |
|
21,819 |
18,844 |
$30K |
| 87186 |
|
5,483 |
4,883 |
$30K |
| 76642 |
|
201 |
172 |
$30K |
| 99156 |
|
1,116 |
1,012 |
$29K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,098 |
9,217 |
$29K |
| 93350 |
|
167 |
157 |
$28K |
| 90633 |
|
1,236 |
1,202 |
$28K |
| 0001A |
|
966 |
886 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,915 |
1,279 |
$27K |
| 93922 |
|
613 |
574 |
$27K |
| 83690 |
|
12,163 |
10,432 |
$26K |
| 84145 |
|
4,533 |
3,935 |
$26K |
| 86901 |
|
9,444 |
8,014 |
$26K |
| 86360 |
|
1,020 |
940 |
$26K |
| 74178 |
|
110 |
105 |
$25K |
| 72170 |
|
1,049 |
970 |
$25K |
| 83516 |
|
2,945 |
2,273 |
$25K |
| 83605 |
|
12,584 |
9,228 |
$25K |
| 97116 |
|
1,786 |
922 |
$25K |
| 0002A |
|
802 |
775 |
$24K |
| 77300 |
|
185 |
149 |
$24K |
| 77334 |
|
164 |
132 |
$24K |
| 88184 |
|
764 |
659 |
$23K |
| 96376 |
|
4,865 |
3,643 |
$23K |
| 83021 |
|
1,875 |
1,357 |
$23K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
15,370 |
12,131 |
$22K |
| 71271 |
|
274 |
259 |
$22K |
| 97166 |
|
480 |
442 |
$22K |
| 93458 |
|
12 |
12 |
$22K |
| 86255 |
|
2,937 |
2,489 |
$22K |
| 85007 |
|
7,396 |
4,404 |
$22K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
162 |
138 |
$21K |
| 85018 |
|
7,326 |
6,416 |
$21K |
| 76380 |
|
220 |
209 |
$21K |
| 73080 |
|
716 |
615 |
$21K |
| 86832 |
|
854 |
707 |
$20K |
| C1769 |
Guide wire |
2,652 |
2,272 |
$20K |
| 93246 |
|
405 |
376 |
$20K |
| 20553 |
|
129 |
122 |
$20K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
6,764 |
4,463 |
$20K |
| 88304 |
|
1,209 |
1,098 |
$20K |
| 17110 |
|
123 |
115 |
$19K |
| 80076 |
|
2,950 |
2,760 |
$19K |
| 82105 |
|
2,051 |
1,932 |
$19K |
| 86706 |
|
2,415 |
2,279 |
$19K |
| 87486 |
|
609 |
575 |
$19K |
| 87581 |
|
609 |
575 |
$19K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
117 |
48 |
$18K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,563 |
12,818 |
$18K |
| 12011 |
|
101 |
97 |
$18K |
| 82043 |
|
6,043 |
5,693 |
$18K |
| 82977 |
|
3,204 |
2,368 |
$18K |
| 90723 |
|
1,871 |
1,828 |
$18K |
| 11981 |
|
50 |
50 |
$18K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,583 |
2,186 |
$17K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
850 |
418 |
$17K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
5,828 |
3,920 |
$17K |
| 94664 |
|
2,008 |
1,790 |
$17K |
| 84153 |
|
1,672 |
1,576 |
$17K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,585 |
3,248 |
$17K |
| 90662 |
|
1,908 |
1,778 |
$17K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,704 |
3,638 |
$17K |
| 97035 |
|
399 |
168 |
$17K |
| 85652 |
|
6,073 |
5,615 |
$16K |
| 87529 |
|
667 |
589 |
$16K |
| 95117 |
|
856 |
408 |
$16K |
| 90620 |
|
161 |
157 |
$16K |
| 72070 |
|
507 |
466 |
$16K |
| 82803 |
|
1,755 |
1,540 |
$16K |
| 84481 |
|
1,607 |
1,551 |
$16K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,546 |
4,239 |
$15K |
| 0003A |
|
668 |
647 |
$15K |
| 83615 |
|
4,842 |
3,207 |
$15K |
| 93226 |
|
320 |
311 |
$15K |
| 82950 |
|
2,824 |
2,686 |
$15K |
| 83550 |
|
1,901 |
1,817 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
289 |
285 |
$14K |
| 72157 |
|
103 |
96 |
$14K |
| 84146 |
|
1,093 |
1,035 |
$14K |
| 87205 |
|
4,521 |
4,110 |
$14K |
| J3535 |
Drug administered through a metered dose inhaler |
2,468 |
1,871 |
$14K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,812 |
1,719 |
$14K |
| 0004A |
|
544 |
525 |
$14K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,759 |
4,424 |
$14K |
| 85379 |
|
5,689 |
5,154 |
$14K |
| 93925 |
|
158 |
152 |
$14K |
| 87210 |
|
3,953 |
3,648 |
$14K |
| 95874 |
|
1,241 |
858 |
$13K |
| 11982 |
|
44 |
42 |
$13K |
| 83520 |
|
1,867 |
1,342 |
$13K |
| 0352U |
|
760 |
695 |
$13K |
| 84156 |
|
5,749 |
5,074 |
$13K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
244 |
122 |
$13K |
| 87040 |
|
3,538 |
1,918 |
$12K |
| 95813 |
|
38 |
38 |
$12K |
| 86833 |
|
780 |
647 |
$12K |
| 76813 |
|
154 |
145 |
$12K |
| 86355 |
|
636 |
605 |
$12K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
139 |
67 |
$12K |
| 76775 |
|
146 |
134 |
$12K |
| 10060 |
|
67 |
63 |
$12K |
| 86704 |
|
1,542 |
1,456 |
$12K |
| 82670 |
|
758 |
724 |
$12K |
| 73090 |
|
544 |
461 |
$11K |
| 82330 |
|
4,079 |
3,438 |
$11K |
| 96416 |
|
38 |
24 |
$11K |
| 83001 |
|
979 |
933 |
$11K |
| 82378 |
|
1,275 |
1,103 |
$11K |
| 86256 |
|
1,346 |
1,151 |
$11K |
| 20550 |
|
46 |
41 |
$11K |
| 41874 |
|
14 |
14 |
$10K |
| 82533 |
|
903 |
706 |
$10K |
| 86902 |
|
653 |
529 |
$10K |
| 97163 |
|
223 |
217 |
$10K |
| 86364 |
|
1,322 |
1,217 |
$10K |
| 85730 |
|
4,688 |
3,753 |
$10K |
| 72158 |
|
63 |
58 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,717 |
2,792 |
$10K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
56 |
51 |
$10K |
| 85014 |
|
5,751 |
4,871 |
$10K |
| A9578 |
Injection, gadobenate dimeglumine (multihance multipack), per ml |
3,153 |
2,972 |
$10K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
11,078 |
9,792 |
$10K |
| 82550 |
|
3,689 |
3,144 |
$9K |
| 90002 |
|
641 |
373 |
$9K |
| 93880 |
|
77 |
73 |
$9K |
| 82565 |
|
2,981 |
2,807 |
$9K |
| 11102 |
|
25 |
24 |
$9K |
| 92567 |
|
1,212 |
1,178 |
$9K |
| 72131 |
|
269 |
240 |
$9K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,700 |
1,474 |
$9K |
| 76512 |
|
53 |
43 |
$9K |
| 52000 |
|
13 |
12 |
$9K |
| 96132 |
|
166 |
154 |
$9K |
| 80164 |
|
1,266 |
1,126 |
$9K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,234 |
1,089 |
$9K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
32 |
12 |
$9K |
| 92025 |
|
145 |
131 |
$9K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
35 |
30 |
$9K |
| 86200 |
|
1,017 |
972 |
$8K |
| 11104 |
|
13 |
13 |
$8K |
| 86334 |
|
1,080 |
995 |
$8K |
| 12002 |
|
29 |
27 |
$8K |
| 90710 |
|
671 |
643 |
$8K |
| G0008 |
Administration of influenza virus vaccine |
3,367 |
3,225 |
$8K |
| 86225 |
|
1,157 |
1,096 |
$8K |
| 94660 |
|
38 |
15 |
$8K |
| 83721 |
|
1,453 |
1,347 |
$8K |
| 69210 |
|
173 |
164 |
$7K |
| 99157 |
|
808 |
718 |
$7K |
| 96127 |
|
521 |
411 |
$7K |
| 74019 |
|
194 |
170 |
$7K |
| 86431 |
|
1,318 |
1,255 |
$7K |
| 90716 |
|
124 |
121 |
$7K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,184 |
2,177 |
$7K |
| 82525 |
|
647 |
620 |
$7K |
| 0054A |
|
269 |
263 |
$7K |
| 85046 |
|
2,294 |
1,745 |
$7K |
| 84270 |
|
649 |
618 |
$7K |
| 87338 |
|
749 |
725 |
$7K |
| 84165 |
|
1,548 |
1,422 |
$7K |
| 64644 |
|
141 |
111 |
$7K |
| 76519 |
|
71 |
65 |
$7K |
| 93247 |
|
174 |
167 |
$7K |
| 64400 |
|
26 |
12 |
$6K |
| 83020 |
|
591 |
550 |
$6K |
| 11900 |
|
27 |
25 |
$6K |
| 86376 |
|
604 |
583 |
$6K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
7,821 |
5,740 |
$6K |
| 85651 |
|
2,189 |
2,015 |
$6K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,307 |
1,587 |
$6K |
| 86141 |
|
721 |
686 |
$6K |
| 64642 |
|
103 |
93 |
$6K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
99 |
91 |
$6K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
729 |
667 |
$6K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,629 |
2,281 |
$6K |
| 73060 |
|
286 |
238 |
$6K |
| 84550 |
|
1,950 |
1,685 |
$6K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
9,550 |
3,504 |
$6K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
18 |
15 |
$6K |
| 87517 |
|
174 |
163 |
$6K |
| 90021 |
|
412 |
233 |
$6K |
| 86038 |
|
685 |
656 |
$5K |
| 82948 |
|
1,799 |
1,716 |
$5K |
| 90696 |
|
330 |
322 |
$5K |
| 87075 |
|
1,774 |
1,559 |
$5K |
| 84703 |
|
1,730 |
1,613 |
$5K |
| 83002 |
|
519 |
500 |
$5K |
| 83030 |
|
660 |
617 |
$5K |
| 76942 |
|
114 |
104 |
$5K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
83 |
52 |
$5K |
| 86160 |
|
827 |
636 |
$5K |
| 91320 |
|
102 |
98 |
$5K |
| 94621 |
|
31 |
28 |
$5K |
| 86708 |
|
728 |
661 |
$5K |
| 88360 |
|
121 |
96 |
$5K |
| 87902 |
|
34 |
32 |
$5K |
| 86301 |
|
644 |
519 |
$5K |
| 84134 |
|
625 |
564 |
$5K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
360 |
299 |
$4K |
| 86849 |
|
1,300 |
1,075 |
$4K |
| P9041 |
Infusion, albumin (human), 5%, 50 ml |
303 |
250 |
$4K |
| 76937 |
|
324 |
271 |
$4K |
| 0071A |
|
149 |
148 |
$4K |
| 72132 |
|
595 |
534 |
$4K |
| 80299 |
|
508 |
452 |
$4K |
| 96368 |
|
742 |
413 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
152 |
145 |
$4K |
| 88313 |
|
549 |
451 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
208 |
193 |
$4K |
| 82040 |
|
1,597 |
1,491 |
$4K |
| 82247 |
|
766 |
507 |
$4K |
| 0297T |
|
66 |
65 |
$4K |
| 86592 |
|
547 |
486 |
$4K |
| 84480 |
|
397 |
381 |
$4K |
| 82465 |
|
879 |
843 |
$4K |
| 84478 |
|
1,105 |
957 |
$4K |
| 82962 |
|
928 |
803 |
$4K |
| 87147 |
|
785 |
747 |
$4K |
| A0200 |
Non-emergency transportation: ancillary: lodging escort |
89 |
12 |
$4K |
| 86800 |
|
422 |
396 |
$4K |
| 84630 |
|
475 |
453 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
2,003 |
1,362 |
$4K |
| 62370 |
|
33 |
26 |
$4K |
| 84446 |
|
591 |
550 |
$4K |
| 86147 |
|
135 |
89 |
$4K |
| 84132 |
|
3,759 |
3,242 |
$4K |
| 82150 |
|
903 |
746 |
$4K |
| 87449 |
|
847 |
773 |
$3K |
| 58301 |
|
15 |
13 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
141 |
132 |
$3K |
| 88312 |
|
394 |
325 |
$3K |
| 92235 |
|
41 |
38 |
$3K |
| 86665 |
|
539 |
283 |
$3K |
| 90746 |
|
152 |
141 |
$3K |
| 36416 |
|
2,154 |
1,797 |
$3K |
| 90480 |
|
132 |
125 |
$3K |
| 77066 |
Tomosynthesis, mammo |
297 |
261 |
$3K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
529 |
508 |
$3K |
| 84425 |
|
469 |
447 |
$3K |
| 90474 |
|
502 |
498 |
$3K |
| 73700 |
|
44 |
41 |
$3K |
| 20611 |
|
12 |
12 |
$3K |
| 87324 |
|
567 |
521 |
$3K |
| 82947 |
|
3,522 |
3,075 |
$3K |
| 91312 |
|
1,217 |
1,176 |
$3K |
| 90656 |
|
120 |
118 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
78 |
66 |
$3K |
| 72129 |
|
523 |
473 |
$3K |
| 84155 |
|
1,265 |
1,159 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
4,966 |
1,397 |
$3K |
| 82248 |
|
843 |
645 |
$3K |
| 80178 |
|
372 |
326 |
$3K |
| 84460 |
|
1,099 |
1,032 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,012 |
868 |
$3K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
18 |
15 |
$2K |
| 96116 |
|
27 |
25 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,167 |
2,585 |
$2K |
| 88262 |
|
50 |
39 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
984 |
933 |
$2K |
| 84295 |
|
3,271 |
2,802 |
$2K |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
19 |
12 |
$2K |
| 92523 |
|
62 |
54 |
$2K |
| 51798 |
|
46 |
41 |
$2K |
| 80177 |
|
361 |
329 |
$2K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
134 |
114 |
$2K |
| 82024 |
|
75 |
68 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,979 |
1,565 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,094 |
696 |
$2K |
| 86663 |
|
304 |
282 |
$2K |
| 74230 |
|
30 |
29 |
$2K |
| 59425 |
|
15 |
12 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
114 |
113 |
$2K |
| 84590 |
|
377 |
346 |
$2K |
| 82610 |
|
221 |
214 |
$2K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
18 |
12 |
$2K |
| 86304 |
|
445 |
358 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
996 |
810 |
$2K |
| 43235 |
|
13 |
13 |
$2K |
| 72128 |
|
146 |
127 |
$2K |
| 84520 |
|
695 |
627 |
$2K |
| 82140 |
|
404 |
342 |
$2K |
| 95970 |
|
28 |
25 |
$2K |
| 72110 |
|
38 |
37 |
$2K |
| 80169 |
|
158 |
85 |
$2K |
| 91307 |
|
274 |
250 |
$2K |
| 86664 |
|
304 |
282 |
$2K |
| 82435 |
|
2,987 |
2,600 |
$2K |
| 76604 |
|
13 |
13 |
$2K |
| 90785 |
|
61 |
56 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,890 |
2,907 |
$2K |
| 74246 |
|
17 |
14 |
$2K |
| 91305 |
|
418 |
403 |
$2K |
| 82390 |
|
149 |
145 |
$2K |
| 94010 |
|
59 |
52 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,492 |
1,151 |
$2K |
| 77062 |
|
81 |
78 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,393 |
1,102 |
$1K |
| 0072A |
|
63 |
63 |
$1K |
| 73120 |
|
45 |
38 |
$1K |
| 96133 |
|
75 |
65 |
$1K |
| 96130 |
|
16 |
12 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
15 |
13 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,397 |
1,095 |
$1K |
| 90700 |
|
125 |
121 |
$1K |
| 86357 |
|
60 |
58 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
380 |
349 |
$1K |
| 82951 |
|
95 |
90 |
$1K |
| 86003 |
|
104 |
63 |
$1K |
| 87102 |
|
525 |
438 |
$1K |
| 80195 |
|
119 |
65 |
$1K |
| J7070 |
Infusion, d5w, 1000 cc |
1,316 |
719 |
$1K |
| 80347 |
|
252 |
157 |
$1K |
| 73564 |
|
41 |
31 |
$1K |
| 86644 |
|
151 |
135 |
$1K |
| 85660 |
|
372 |
235 |
$1K |
| 82010 |
|
790 |
651 |
$1K |
| 80179 |
|
4,052 |
3,386 |
$994.92 |
| 84144 |
|
80 |
72 |
$975.82 |
| G0473 |
Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes |
60 |
43 |
$969.40 |
| 88112 |
|
52 |
42 |
$966.78 |
| 80143 |
|
4,115 |
3,427 |
$958.26 |
| 94667 |
|
42 |
37 |
$952.04 |
| 83521 |
|
410 |
261 |
$939.31 |
| 87385 |
|
151 |
119 |
$902.98 |
| 82627 |
|
73 |
70 |
$902.33 |
| 86696 |
|
133 |
125 |
$898.80 |
| 99497 |
|
112 |
104 |
$882.25 |
| 80326 |
|
246 |
151 |
$868.32 |
| 83525 |
|
76 |
70 |
$864.23 |
| 84445 |
|
26 |
24 |
$828.82 |
| 86593 |
|
123 |
112 |
$827.05 |
| 82103 |
|
114 |
109 |
$811.65 |
| 82542 |
|
28 |
27 |
$806.14 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
643 |
348 |
$801.16 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
550 |
171 |
$784.66 |
| 88280 |
|
56 |
44 |
$783.86 |
| 73620 |
|
34 |
25 |
$782.40 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,270 |
1,440 |
$764.95 |
| 76857 |
|
12 |
12 |
$763.37 |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
24 |
15 |
$761.02 |
| 85055 |
|
40 |
39 |
$710.61 |
| 77065 |
Tomosynthesis, mammo |
75 |
65 |
$708.51 |
| 87807 |
|
50 |
47 |
$697.61 |
| 86769 |
|
28 |
27 |
$676.92 |
| 83718 |
|
104 |
99 |
$672.56 |
| 84450 |
|
279 |
265 |
$661.54 |
| 81511 |
|
13 |
13 |
$650.00 |
| 92611 |
|
14 |
14 |
$637.37 |
| 83993 |
|
51 |
49 |
$620.38 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,026 |
759 |
$612.39 |
| 81015 |
|
590 |
551 |
$608.60 |
| 88271 |
|
41 |
30 |
$594.96 |
| 0052A |
|
18 |
18 |
$582.17 |
| 0296T |
|
15 |
13 |
$579.03 |
| 83921 |
|
98 |
93 |
$565.86 |
| 62369 |
|
30 |
28 |
$561.88 |
| 11100 |
|
12 |
12 |
$543.60 |
| 86695 |
|
70 |
66 |
$539.64 |
| 96139 |
|
13 |
12 |
$516.32 |
| 92593 |
|
33 |
31 |
$514.80 |
| 94760 |
|
472 |
421 |
$513.96 |
| Q5105 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units |
23 |
14 |
$512.03 |
| 83090 |
|
68 |
66 |
$504.39 |
| 90707 |
|
64 |
64 |
$502.64 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,135 |
898 |
$489.83 |
| J3480 |
Injection, potassium chloride, per 2 meq |
884 |
637 |
$482.03 |
| 82952 |
|
96 |
90 |
$453.01 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
980 |
893 |
$452.86 |
| 82785 |
|
42 |
39 |
$446.65 |
| L0140 |
Cervical, semi-rigid, adjustable (plastic collar) |
27 |
24 |
$434.32 |
| 80364 |
|
248 |
153 |
$434.07 |
| 80355 |
|
248 |
153 |
$434.06 |
| 84432 |
|
38 |
36 |
$430.98 |
| C1780 |
Lens, intraocular (new technology) |
493 |
402 |
$426.47 |
| 89051 |
|
432 |
361 |
$417.54 |
| 93282 |
|
14 |
12 |
$417.22 |
| 80158 |
|
70 |
51 |
$407.62 |
| 29125 |
|
14 |
12 |
$407.40 |
| 85520 |
|
189 |
151 |
$400.60 |
| 86580 |
|
33 |
25 |
$364.35 |
| J7999 |
Compounded drug, not otherwise classified |
32 |
28 |
$359.83 |
| 77001 |
|
51 |
42 |
$348.21 |
| 0051A |
|
13 |
13 |
$347.27 |
| 88275 |
|
42 |
30 |
$347.06 |
| 70250 |
|
14 |
14 |
$337.26 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55 |
52 |
$337.00 |
| 92136 |
|
14 |
14 |
$332.01 |
| C1729 |
Catheter, drainage |
468 |
401 |
$328.78 |
| G0009 |
Administration of pneumococcal vaccine |
896 |
856 |
$319.57 |
| 73070 |
|
48 |
41 |
$310.31 |
| 70350 |
|
12 |
12 |
$301.13 |
| 82274 |
|
28 |
26 |
$300.09 |
| J1956 |
Injection, levofloxacin, 250 mg |
16 |
15 |
$295.95 |
| 83010 |
|
88 |
76 |
$286.76 |
| 84207 |
|
55 |
54 |
$281.11 |
| 88311 |
|
112 |
91 |
$272.87 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
562 |
483 |
$272.29 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
19 |
14 |
$270.13 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
9,005 |
7,544 |
$266.13 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
716 |
685 |
$255.52 |
| 86308 |
|
79 |
78 |
$253.82 |
| 80349 |
|
33 |
27 |
$232.19 |
| 76870 |
|
53 |
51 |
$230.68 |
| 84206 |
|
13 |
12 |
$221.32 |
| L3906 |
Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
60 |
52 |
$219.19 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
271 |
263 |
$179.92 |
| 91308 |
|
17 |
17 |
$174.79 |
| 82671 |
|
12 |
12 |
$171.02 |
| 86645 |
|
25 |
24 |
$161.90 |
| 83883 |
|
18 |
14 |
$145.27 |
| 90685 |
|
40 |
38 |
$143.33 |
| 85613 |
|
56 |
52 |
$136.99 |
| 87116 |
|
135 |
93 |
$129.44 |
| 86300 |
|
19 |
16 |
$126.39 |
| 86381 |
|
30 |
28 |
$122.38 |
| A0190 |
Non-emergency transportation: ancillary: meals-recipient |
43 |
12 |
$119.92 |
| 83519 |
|
21 |
12 |
$113.12 |
| 85670 |
|
56 |
52 |
$109.79 |
| 95249 |
|
116 |
111 |
$106.78 |
| 87015 |
|
58 |
39 |
$106.56 |
| 86341 |
|
15 |
13 |
$106.05 |
| 86015 |
|
29 |
28 |
$99.96 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
16 |
13 |
$96.42 |
| 87206 |
|
113 |
79 |
$90.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,943 |
884 |
$86.49 |
| J7607 |
Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg |
26 |
18 |
$85.32 |
| 86060 |
|
13 |
12 |
$83.16 |
| 86709 |
|
16 |
14 |
$76.23 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
89 |
52 |
$75.91 |
| A9573 |
Injection, gadopiclenol, 1 ml |
94 |
90 |
$74.10 |
| 96040 |
|
599 |
572 |
$68.64 |
| J1940 |
Injection, furosemide, up to 20 mg |
759 |
406 |
$67.33 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
19 |
13 |
$65.10 |
| J7510 |
Prednisolone oral, per 5 mg |
32 |
24 |
$60.78 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
196 |
147 |
$58.32 |
| 82104 |
|
12 |
12 |
$56.00 |
| 91300 |
|
3,389 |
3,018 |
$45.04 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
19 |
12 |
$41.35 |
| 84300 |
|
46 |
43 |
$35.44 |
| 83935 |
|
14 |
13 |
$25.40 |
| 85384 |
|
20 |
12 |
$24.99 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,153 |
1,058 |
$18.58 |
| 85347 |
|
125 |
69 |
$16.22 |
| 98968 |
|
45 |
29 |
$15.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,070 |
3,631 |
$7.49 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
108 |
98 |
$6.63 |
| S4990 |
Nicotine patches, legend |
1,512 |
662 |
$5.31 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
27 |
13 |
$5.12 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
276 |
150 |
$4.11 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
156 |
144 |
$2.57 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
495 |
418 |
$0.93 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
503 |
341 |
$0.92 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,577 |
1,303 |
$0.90 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
73 |
56 |
$0.07 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
465 |
414 |
$0.01 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
468 |
418 |
$0.01 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
329 |
296 |
$0.01 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
328 |
296 |
$0.01 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
13 |
13 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
16 |
14 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
76 |
50 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
74 |
68 |
$0.00 |
| A6457 |
Tubular dressing with or without elastic, any width, per linear yard |
291 |
211 |
$0.00 |
| 96402 |
|
67 |
52 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
195 |
182 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
18 |
13 |
$0.00 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
88 |
81 |
$0.00 |
| 92504 |
|
28 |
25 |
$0.00 |
| 96136 |
|
33 |
29 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
60 |
56 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
29 |
25 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
30 |
28 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
50 |
36 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
19 |
12 |
$0.00 |
| 96138 |
|
13 |
12 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
334 |
145 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
123 |
115 |
$0.00 |
| 95911 |
|
14 |
13 |
$0.00 |
| Q0164 |
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
67 |
42 |
$0.00 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
52 |
39 |
$0.00 |
| 84157 |
|
14 |
14 |
$0.00 |
| 92285 |
|
16 |
12 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
24 |
15 |
$0.00 |
| 92002 |
|
26 |
24 |
$0.00 |
| 87071 |
|
15 |
12 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
40 |
36 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
51 |
27 |
$0.00 |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
28 |
27 |
$0.00 |